At Ketavita Wellness Clinic, we offer specialized IV ketamine therapy for fibromyalgia that hasn’t responded adequately to traditional treatments. When conventional medications like pregabalin, duloxetine, or milnacipran haven’t provided sufficient relief from widespread chronic pain, fatigue, and other fibromyalgia symptoms, our ketamine infusions offer a different approach through NMDA receptor modulation that targets central sensitization and disordered pain processing.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand how debilitating fibromyalgia can be. We create personalized treatment protocols designed to help you achieve meaningful pain reduction and improved quality of life.
Every treatment journey begins with a comprehensive evaluation where we review your fibromyalgia symptoms including widespread pain locations and severity, fatigue levels and sleep disturbances, cognitive symptoms (“fibro fog”), other symptoms like headaches or irritable bowel, when symptoms began and their progression, previous treatments you’ve tried including medications and therapies, and how fibromyalgia affects your daily functioning. We work closely with you throughout treatment, monitoring your response and adjusting protocols to optimize outcomes.
Fibromyalgia is a complex chronic disorder affecting approximately 2-4% of the population, characterized by widespread musculoskeletal pain without identifiable physical or laboratory signs of tissue damage. This condition predominantly affects women (80-90% of cases) and typically develops during middle age, though it can occur at any age.
The hallmark symptom of fibromyalgia is chronic widespread pain affecting multiple body regions. This pain is often described as a constant dull ache, burning sensation, or deep muscle soreness affecting both sides of the body, above and below the waist. The pain typically involves muscles, tendons, and ligaments rather than joints, and its intensity fluctuates over time, often worsening with physical activity, stress, weather changes, or lack of sleep.
Fatigue is another central feature of fibromyalgia. Most people with this condition experience profound exhaustion that isn’t relieved by rest. This fatigue can be so severe that it significantly limits daily activities and work capacity. Sleep disturbances are nearly universal, with most patients reporting non-restorative sleep—waking feeling unrefreshed despite sleeping adequate hours. Many also experience specific sleep disorders like sleep apnea or restless legs syndrome.
Cognitive difficulties, often called “fibro fog,” affect concentration, memory, and mental clarity. People describe difficulty focusing on tasks, trouble finding words, problems with short-term memory, and feeling mentally sluggish or confused. These cognitive symptoms can be as disabling as the physical pain for many individuals.
Additional symptoms commonly include chronic headaches or migraines, temporomandibular joint dysfunction, irritable bowel syndrome, painful bladder syndrome, heightened sensitivity to lights, sounds, or temperature, numbness or tingling in hands and feet, and increased sensitivity to touch (allodynia) where normally non-painful stimuli cause pain. The constellation of these symptoms significantly impairs quality of life and functioning.
While the exact cause of fibromyalgia remains incompletely understood, research has identified key mechanisms involving central sensitization—an amplification of pain signals in the central nervous system. In fibromyalgia, the nervous system becomes hypersensitive, processing pain signals abnormally and perceiving pain from stimuli that wouldn’t normally be painful.
This central sensitization involves dysregulation of neurotransmitters including glutamate, the primary excitatory neurotransmitter in the nervous system. People with fibromyalgia show elevated glutamate levels in specific brain regions involved in pain processing. Excessive glutamate activity through NMDA receptors contributes to the maintenance of central sensitization and chronic pain states.
Additionally, fibromyalgia involves imbalance between excitatory and inhibitory neurotransmission in the brain and spinal cord. While glutamate-mediated excitation is increased, inhibitory pain-modulating systems are impaired. This combination results in amplified pain signals and reduced natural pain inhibition.
Brain imaging studies reveal altered activity in pain-processing regions including the insula, anterior cingulate cortex, and sensory cortex. These changes reflect the neuroplastic alterations that occur with chronic pain, where the nervous system essentially “learns” to amplify pain signals over time.
Understanding these mechanisms explains why typical pain medications like NSAIDs or opioids, which target peripheral pain pathways or inflammation, are generally ineffective for fibromyalgia. The pain originates from central nervous system dysfunction rather than peripheral tissue damage, requiring treatments that address central sensitization mechanisms.
Ketamine functions as a noncompetitive antagonist of NMDA receptors, which play a critical role in central sensitization and chronic pain maintenance. By blocking these receptors, ketamine interrupts the excessive glutamatergic signaling that contributes to fibromyalgia pain amplification.
The NMDA receptor antagonism produces several beneficial effects for fibromyalgia. First, it directly reduces nociceptive hypersensitivity—the heightened pain sensitivity characteristic of this condition. By blocking NMDA-mediated glutamate transmission in the spinal cord and brain, ketamine helps normalize pain processing that has become dysfunctional.
Second, ketamine may reduce temporal summation, a phenomenon where repeated pain signals become increasingly amplified—essentially “wind-up” of pain transmission. This wind-up phenomenon is prominently featured in fibromyalgia, and ketamine’s ability to interrupt it provides meaningful pain relief.
Third, ketamine promotes neuroplasticity through increased brain-derived neurotrophic factor and synaptic remodeling. These neuroplastic effects may help reverse some of the maladaptive neural changes that maintain chronic pain states, potentially providing benefits that extend beyond the immediate effects of the infusion.
Additionally, ketamine affects other receptor systems beyond NMDA receptors, including opioid receptors and inflammatory pathways, which may contribute to its analgesic effects. The medication also has demonstrated anti-inflammatory properties that could be relevant for fibromyalgia, though inflammation isn’t the primary driver of this condition.
The rapid onset of ketamine’s analgesic effects distinguishes it from conventional fibromyalgia medications like duloxetine or pregabalin, which require weeks of daily use to achieve maximum benefit. Ketamine research shows pain reduction can occur within hours after infusion, potentially providing relatively quick relief for patients with severe symptoms.
Your fibromyalgia treatment journey at Ketavita begins with a thorough evaluation. We’ll discuss your pain characteristics including which body regions are affected, pain severity on average and at its worst, factors that worsen or improve your pain, how pain affects your sleep, work, and daily activities, and whether you experience specific tender points.
We’ll also review additional symptoms: fatigue levels and their impact, sleep quality and any diagnosed sleep disorders, cognitive difficulties you experience, other symptoms like headaches or bowel issues, and psychological symptoms including depression or anxiety that often coexist with fibromyalgia.
Your treatment history is important: all medications tried including SNRIs, anticonvulsants, and others, with their effectiveness and side effects; physical therapy, exercise programs, or other interventions; complementary approaches like acupuncture or massage; and current medications you’re taking. This comprehensive assessment helps us determine if ketamine therapy is appropriate and develop an optimal treatment protocol.
For IV ketamine therapy for fibromyalgia, treatment protocols differ from those used for mental health conditions. Chronic pain protocols typically involve longer infusion times—often 2-4 hours depending on your specific needs and tolerance—allowing for higher cumulative doses that research suggests may be necessary for sustained pain relief in fibromyalgia.
During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout the extended infusion. You may experience dissociative effects during treatment—feelings of detachment, altered perception, or mild euphoria—but these are temporary and typically resolve within 1-2 hours after the infusion ends.
Side effects during infusion are generally mild and transient. Common side effects include temporary dissociative feelings lasting up to 30 minutes after infusion, dizziness or lightheadedness, mild nausea (less common), brief changes in hearing or visual perception, and drowsiness or euphoria. These effects are short-lasting and typically resolve quickly after treatment completion.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home.
Response to ketamine therapy for fibromyalgia varies significantly among individuals. Research shows that low-dose ketamine infusions (0.3-0.5 mg/kg) can provide short-term pain reduction lasting from a few hours up to several days after infusion. Some studies suggest that higher doses, longer infusion times, and repeated treatments may result in more sustained pain relief, though the evidence base remains limited compared to ketamine’s use in other conditions.
Most fibromyalgia treatment protocols involve a series of infusions rather than single treatments. Initial series typically consist of 4-8 infusions over several weeks, with maintenance sessions scheduled based on your individual response and duration of pain relief. We use standardized pain assessment tools to track your progress and adjust treatment protocols accordingly.
Ketamine therapy for fibromyalgia may be appropriate if you’ve struggled with persistent pain and symptoms despite conventional treatment attempts. You may be a candidate if you’ve tried at least two different FDA-approved fibromyalgia medications (like duloxetine, milnacipran, or pregabalin) without adequate pain relief, engaged in recommended therapies including exercise, cognitive behavioral therapy, or other approaches without sufficient benefit, found that combination treatments haven’t provided satisfactory symptom control, or continue to have widespread pain significantly impairing your quality of life and functioning despite treatment.
Good candidates for ketamine therapy are adults with diagnosed fibromyalgia who remain significantly symptomatic despite appropriate trials of first-line treatments. Research on ketamine for fibromyalgia has included patients with varying disease duration and symptom severity.
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health (ketamine temporarily raises blood pressure, particularly important with longer infusions), history of psychiatric conditions including psychosis or severe dissociative disorders, substance use history, current medications including those that might interact with ketamine, and any other medical conditions affecting treatment safety. Your complete medical history helps ensure safe, appropriate treatment.
It’s important to understand that ketamine therapy for fibromyalgia represents off-label use, and the evidence base is more limited than for some other chronic pain conditions. While studies demonstrate short-term pain reduction, research on long-term efficacy remains limited. Most studies have been small, and optimal dosing protocols aren’t fully established. We discuss current research findings transparently during consultation so you can make fully informed treatment decisions.
Our ketamine protocols for fibromyalgia are informed by available research demonstrating pain reduction in treatment-resistant cases. Systematic reviews show that IV ketamine infusions at doses of 0.3-0.5 mg/kg can reduce pain scores in fibromyalgia patients, with effects ranging from hours to days following treatment. Some evidence suggests dose-response relationships, where higher cumulative doses and longer, more frequent infusions may provide more effective and longer-lasting pain relief.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades at much higher anesthetic doses, and we follow established safety protocols for subanesthetic dosing in chronic pain applications. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols. The extended infusion times required for pain treatment necessitate careful monitoring, which we provide throughout your treatment.
We recognize that effective fibromyalgia management requires comprehensive, multidisciplinary treatment. While ketamine can provide pain relief, we strongly encourage continued engagement with other evidence-based fibromyalgia interventions including regular low-impact aerobic exercise (which has strong evidence for fibromyalgia), cognitive behavioral therapy for pain management, sleep hygiene and treatment of sleep disorders, stress management techniques, and appropriate medications when beneficial.
Ketamine should be viewed as one component of comprehensive fibromyalgia management rather than a standalone cure. The condition requires ongoing management across multiple domains, and optimal outcomes typically come from combining various therapeutic approaches tailored to your specific symptom profile.
Patient education is essential to our approach. We ensure you understand how ketamine works differently from conventional fibromyalgia medications, what the research shows about efficacy and duration of effects, realistic expectations given current evidence, potential side effects or risks, and how ketamine fits into comprehensive fibromyalgia management. Informed patients with realistic expectations are better positioned to achieve optimal outcomes.
Ketamine therapy for fibromyalgia is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for fibromyalgia and other chronic pain conditions is $1,000 per session. The extended infusion protocols required for chronic pain treatment (typically 2-4 hours compared to 40 minutes for mental health conditions) necessitate this pricing. A typical initial treatment series involves 4-8 infusions over several weeks, with maintenance sessions scheduled as needed based on your individual response and duration of pain relief.
The total investment depends on how many sessions you require, whether you respond favorably to treatment, and whether ongoing maintenance is necessary to sustain benefits. Given the limited long-term research, it’s difficult to predict how long benefits will last for any individual patient.
We understand that cost is a significant consideration, especially after already trying multiple treatments without success and managing the ongoing expenses of fibromyalgia care. However, many patients with treatment-resistant fibromyalgia find that even modest pain reduction and improved functioning significantly improve their quality of life and ability to work or engage in daily activities, potentially justifying the investment.
While insurance typically doesn’t cover ketamine therapy for fibromyalgia, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. For an additional $50 fee, we can prepare detailed documentation for insurance submission. Coverage decisions are made by individual insurance companies based on their policies, and approval is not guaranteed.
If you’ve been struggling with fibromyalgia despite trying conventional treatments, IV ketamine therapy at Ketavita Wellness Clinic may offer new hope. Our evidence-based approach provides pain relief through NMDA receptor antagonism that targets central sensitization differently than standard fibromyalgia medications.
Schedule a consultation to discuss your fibromyalgia symptoms and their impact on your life, review your treatment history and previous responses, explore whether ketamine therapy is appropriate for your situation, and develop a personalized treatment protocol designed to help you achieve better pain control and improved quality of life.
Living with treatment-resistant fibromyalgia is exhausting and limiting, but you don’t have to accept persistent widespread pain and disability. Contact us today to learn how ketamine therapy can help you find the relief you’ve been seeking.
Research shows ketamine can provide short-term pain reduction in fibromyalgia patients. Studies demonstrate that IV ketamine infusions at doses of 0.3-0.5 mg/kg can reduce pain scores, with effects lasting from a few hours to several days. Some evidence suggests higher doses and more frequent infusions may provide longer-lasting relief, though research is limited compared to other conditions.
Duration varies significantly among individuals. Most research shows short-term effects lasting hours to days after a single infusion. Some studies report pain relief extending up to one week. Evidence suggests that repeated infusions and higher cumulative doses may provide more sustained benefits, but long-term efficacy data remains limited.
Chronic pain protocols involve significantly longer infusion times (typically 2-4 hours compared to 40 minutes for mental health conditions) and may use higher cumulative doses. The extended protocol allows for greater NMDA receptor blockade thought to be necessary for sustained pain relief. Pricing reflects these longer, more intensive treatment sessions.
Most protocols involve an initial series of 4-8 infusions over several weeks. Maintenance sessions may be needed to sustain benefits, with frequency determined by your individual response. Because research on optimal dosing protocols is limited, treatment plans are individualized based on your response.
Yes, in most cases. Many patients receive ketamine therapy while continuing their existing medication regimen including SNRIs, anticonvulsants, or other fibromyalgia medications. We’ll review all your current medications during consultation to ensure there are no contraindications. Never discontinue medications without consulting your prescribing physician.
No. Ketamine is not a cure for fibromyalgia. It’s a treatment that can provide pain relief, potentially allowing you to engage more effectively in other therapeutic activities like exercise and physical therapy. Fibromyalgia is a chronic condition requiring ongoing, multidisciplinary management.
Yes, ketamine has been studied for various chronic pain conditions including neuropathic pain, complex regional pain syndrome (CRPS), and phantom limb pain. Our clinic offers ketamine therapy for multiple chronic pain conditions. The evidence base varies across different pain types.
Pain Management
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481